-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Finch Therapeutics Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$4.83M, a 30.4% increase year-over-year.
- Finch Therapeutics Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$14.2M, a 89.6% increase year-over-year.
- Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$74.8M, a 34.8% increase from 2022.
- Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$115M, a 97.1% decline from 2021.
- Finch Therapeutics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$58.2M, a 47.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)